Several lncRNAs have been shown to regulate glucose metabolism and be associated with the pathology of type 2 DM (T2DM) (38, 53), involving changes in the growth of pancreatic β-cell, insulin synthesis, insulin secretion, and insulin signaling in target tissues (including liver, skeletal muscle, and adipocyte). This evidence concerns the gene INS and type 2 diabetes mellitus.